Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 20, 2022 | Post-IPO Equity | $86.30M | — | — | — | Detail |
Aug 12, 2022 | Post-IPO Equity | $65M | 2 | Fairmount Funds Management , Venrock Healthcare Capital Partners | — | Detail |
Feb 4, 2021 | IPO | $127.50M | — | — | — | Detail |
Jan 5, 2021 | Series C | $87M | 7 | Deepfield , Eli Lilly | — | Detail |
Oct 30, 2018 | Series B | $80M | 4 | OrbiMed , Vivo Capital | — | Detail |
Apr 4, 2018 | Series A | $30M | 1 | Lilly Asia Ventures | — | Detail |